Vancouver, B.C., December 29, 2017 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada (“IIROC”) to comment on recent trading activity of its stock.

IIROC monitors continuous trading in all listed issuers. To assist in this monitoring, IIROC utilizes single stock circuit breakers (SSCB’S) which trigger when price movements occur beyond certain thresholds.  SSCB’s trigger a 5-minute pause in trading when these moves occur. Trading was paused and set to resume within 5 minutes.  Immediately following the resumption, a second SSCB triggered due to the price increase immediately following the resumption. Due to two of these triggering in such a short window staff at IIROC decided to halt trading pending company contact to obtain an explanation for the price movement.

The Company announces that it is not aware of any material, undisclosed corporate developments and has no material change to report at this time. The Company will keep the market informed as required.

The Company is on track with respect to its stated goals and timelines in achieving those goals.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products.  MYM has two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a partner in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.  MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD

Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mymarijuana.ca

Investor Relations
Terry Brown
1.855.696.2261
terry@mymarijuana.ca